Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01700751
What this trial is testing

Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, Acute MyeloidLeukemia, Lymphoblastic,AcuteMyelodysplastic Syndromes
Washington University School of Medicine 17
Testing effectiveness (Phase 2)Ended earlyNCT05502783
What this trial is testing

Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Who this might be right for
Immune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD
National Heart, Lung, and Blood Institute (NHLBI) 1
Testing effectiveness (Phase 2)Looking for participantsNCT06793410
What this trial is testing

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Who this might be right for
Recipients of Allogeneic Stem Cell TransplantationHPV (Human Papillomavirus)-AssociatedAcute Myeloid Leukaemia+2 more
Vastra Gotaland Region 100
Testing effectiveness (Phase 2)Looking for participantsNCT06828796
What this trial is testing

Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide

Who this might be right for
Hematologic Disease and DisordersHematopoietic Cell Transplant
Northside Hospital, Inc. 20
Early research (Phase 1)Looking for participantsNCT06498973
What this trial is testing

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 43
Not applicableNot Yet RecruitingNCT07289087
What this trial is testing

Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T Therapy

Who this might be right for
Quality of LifePatient Reported Outcome (PRO)Allogeneic Blood and Marrow Transplantation (BMT)+1 more
Associazione Qol-one 162
Testing effectiveness (Phase 2)Ended earlyNCT06271616
What this trial is testing

Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm
Mayo Clinic 2
Testing effectiveness (Phase 2)UnknownNCT06141304
What this trial is testing

Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT

Who this might be right for
Relapsed Adult ALLRelapsed Adult AML
The First Hospital of Jilin University 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT07157514
What this trial is testing

Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

Who this might be right for
Acute LeukemiaMyeloid LeukemiaAcute Myelogenous Leukemia+8 more
Actinium Pharmaceuticals 306
Not applicableEnded earlyNCT00008216
What this trial is testing

Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Adult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more
Columbia University 48
Testing effectiveness (Phase 2)Study completedNCT01455051
What this trial is testing

Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Chronic Lymphocytic Leukemia
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 25
Testing effectiveness (Phase 2)WithdrawnNCT04720742
What this trial is testing

Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation

Who this might be right for
HIV Infection
IrsiCaixa
Not applicableStudy completedNCT00427661
What this trial is testing

A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen

Who this might be right for
Sickle Cell DiseaseThalassemiaHemoglobinopathies
University of Pittsburgh 8
Large-scale testing (Phase 3)Study completedNCT02913261
What this trial is testing

Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation

Who this might be right for
Corticosteroid Refractory Acute Graft vs Host Disease
Novartis Pharmaceuticals 310
Testing effectiveness (Phase 2)Ended earlyNCT02350777
What this trial is testing

T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell TransplantPoor Marrow Graft Function
Memorial Sloan Kettering Cancer Center 4
Early research (Phase 1)Ended earlyNCT00325741
What this trial is testing

Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Stanford University 1
Not applicableLooking for participantsNCT07763054
What this trial is testing

Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome+6 more
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine 30
Not applicableLooking for participantsNCT07588594
What this trial is testing

Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic Leukemia (CMML)
Peking University People's Hospital 31
Large-scale testing (Phase 3)Study completedNCT00750737
What this trial is testing

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

Who this might be right for
Invasive Fungal InfectionsHematologic Malignancies
M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Ended earlyNCT01773395
What this trial is testing

GVAX vs. Placebo for MDS/AML After Allo HSCT

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Dana-Farber Cancer Institute 123
Next Page